The Role of Mitochondrial Superoxide Dismutase (SOD2) During a Coxiella Burnetii Infection by Champaigne, Rachel Diantha
Portland State University
PDXScholar
University Honors Theses University Honors College
2015
The Role of Mitochondrial Superoxide Dismutase (SOD2)
During a Coxiella Burnetii Infection
Rachel D. Champaigne
Portland State University
Let us know how access to this document benefits you.
Follow this and additional works at: http://pdxscholar.library.pdx.edu/honorstheses
This Thesis is brought to you for free and open access. It has been accepted for inclusion in University Honors Theses by an authorized administrator of
PDXScholar. For more information, please contact pdxscholar@pdx.edu.
Recommended Citation
Champaigne, Rachel D., "The Role of Mitochondrial Superoxide Dismutase (SOD2) During a Coxiella Burnetii Infection" (2015).
University Honors Theses. Paper 160.
10.15760/honors.168
  
i 
The Role of Mitochondrial Superoxide Dismutase (SOD2) During a Coxiella burnetii 
Infection 
Rachel Diantha Champaigne 
 
 
 
 
An undergraduate honors thesis submitted in partial fulfillment of the requirements for the 
degree of 
Bachelor of Science 
in 
University Honors 
and 
Biology 
 
 
 
 
 
Thesis Advisor 
Rahul Raghavan 
Portland State University 
2015 
  
ii
 
  
  
iii
RESEARCH QUESTION 
What is the role of Mitochondrial Superoxide Dismutase (SOD2) during a Coxiella burnetii 
infection in human cells? 
 
  
  
iv
ABSTRACT 
 
Coxiella burnetii is the etiological agent of acute Q fever and highly fatal chronic endocarditis in       
humans. It is an intracellular bacterial pathogen that initially invades macrophages and thrives 
within a lysosome-like parasitophorous vacuole by modifying host processes. Expression 
analyses of THP-1 cells (human monocyte/macrophage cell line) using RNA-seq show 
differential expression of several host genes in C. burnetii infected cells when compared to 
uninfected cells. Mitochondrial Superoxide Dismutase (SOD2) expression is highly upregulated 
(8x) during C. burnetii infection as opposed to uninfected cells, but it is unknown if this 
expression pattern is a host immune response to suppress Coxiella growth or whether Coxiella 
induces it to promote its own intracellular growth. To understand the function of SOD2 during 
Coxiella infection in human macrophages, a targeted RNA silencing approach (siRNA) was used 
to knock down SOD2 gene expression in HeLa and THP-1 cells. An increase in the levels of C. 
burnetii infection would have indicated that the increased expression of SOD2 is a host response 
to control intracellular bacteria.  Conversely, a decrease in C. burnetii numbers would have 
suggested that SOD2 expression is beneficial to Coxiella and is induced by the bacterium to 
promote intracellular growth. A significant transfection was not completed in the HeLa cell line, 
due to cytotoxicity of liposome delivery system. The change in bacterial growth in THP-1 cells 
that were transfected with a siRNA targeting the SOD2 transcript was insignificant. A gene 
expression analysis indicated that the success of the transfection was at about 30%, and therefore 
did not significantly affect the bacterial growth rate. When a more successful transfection 
method is optimized, the question can be revisited. 
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CHAPTER I 
INTRODUCTION 
   
Coxiella burnetii is an intracellular pathogen that causes Q-fever and chronic endocarditis in 
humans.1 Coxiella is able to withstand many environmental challenges, including UV light, rapid 
temperature change, and osmotic stresses2. It does so through a stasis-type variant (small cell 
variant), which can be aerosolized and inhaled. It is typically transmitted to humans in 
agricultural areas with large populations of sheep or goats, though recent research has found 
evidence of transmission from wildlife to humans3. When Coxiella is inhaled, it is endocytosed 
into a phagosome (Figure 14). As the phagosome fuses with an endosome and transits through 
the endocytic cascade, its internal pH drops due to the accumulation of hydrogen pumps as the 
membrane fuses and grows. At the end of the cascade, the phagosome fuses with the lysosome5,6.  
 
The lysosome is traditionally the location in which all pathogens, misfolded proteins, and 
other cellular debris go to be broken down and recycled for the cell’s needs. It is in this organelle 
that C. burnetii thrives, and replicates into both large cell variants (LCVs), the replicative form, 
and small cell variants (SCV), the infective form7,8. The lysosome at this stage becomes a 
replicative parasitophorous vacuole (PV). During the replicative phase, the host continues to 
send cellular waste to the lysosome (now a PV) to be degraded. Coxiella uses the cellular waste 
for its own metabolic needs9. As the quantity of bacteria in the PV increases, the size of the PV 
membrane grows by fusing with other endocytic vesicles9. C. burnetii has a type IV secretion 
system with which it delivers protein effectors to the host cytosol10,11,12. These effectors control 
the host’s expression of specific genes; modifying cytoplasmic filament placement, apoptotic 
pathway, mitotic signals, lipid production, and host immune responses13.  
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Changes in expression patterns of host genes can be determined through High 
Throughput RNA sequencing (RNA-seq)14, which is a process in which the whole transcriptome, 
or all cellular RNA present at one time, can be collected and analyzed. Previously, we performed 
an RNA-seq analysis of THP-1 cells infected with C. burnetii and identified several genes that 
were differentially expressed in infected cells compared to non-infected cells. Expression 
changes can be an immune response of the host to the pathogen15 or they can be a result effectors 
secreted by the pathogen via a type IV secretion system.  
  
 A small interfering RNA (siRNA) is a short nucleotide sequence that can bind to 
transcribed mRNA, either prior to or after the splicing out of introns. The siRNA can also bind to 
the active site of a targeted protein, inhibiting the active site and blocking interactions between it 
and other peptides; this may also modify the structure of the protein, interfering with its function.  
 
To determine which host factors were involved in expression changes during a Coxiella 
burnetii infection in HeLa cells, McDonough et al.16 performed a whole human genome-wide 
siRNA knockdown, in infected and uninfected cells. This included silencing of 21,121 individual 
human genes in 384-well plates, then using fluorescence imaging and analysis of size and 
quantity of the C. burnetii parasitophorous vacuoles in the cells. The quantity and size of the PVs 
allowed for the identification of host proteins were the most important for C. burnetii growth 
within HeLa cells16. 
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In our RNA-seq analysis in THP-1 cells, one gene that was found to be significantly 
upregulated during C. burnetii infection of THP-1 cells is mitochondrial superoxide dismutase 
(SOD2)14,17. We found the expression of SOD2 to be upregulated by eight times the amount of 
an uninfected cell. This gene was not specifically discussed in McDonough’s paper, though it 
showed a similar amount of upregulation in their supplementary data sheets.  
 
The SOD2 protein itself is a heterotetramer that binds one manganese ion per segment. 
When superoxide ions are produced through normal oxidative phosphorylation processes, SOD2 
uses the manganese ion to convert the superoxide radicals (O2-) to hydrogen peroxide (H2O2) and 
diatomic oxygen (O2), effectively neutralizing the reactive oxygen species (ROS). Hydrogen 
peroxide is then further broken down by an enzyme called catalase (figure 2).  
 
During an infection, it is believed that the host cell makes SOD2 and stores it in the 
mitochondria while it initiates a full-scale superoxide attack on the pathogen, then releases its 
SOD2 to neutralize the superoxide after the assault so that it does not harm the host. C. burnetii 
is known to combat oxidative stress from host assault with antioxidants like glutathione, vitamins 
A,C, and E, and carotenoids, as well as other molecular neutralizing agents19,20. It is also 
suspected that an acid phosphatase is secreted through C. burnetii type IV secretion system to 
neutralize the oxygen free radicals18. Superoxide dismutase could benefit the host by neutralizing 
the superoxide ions after the immune attack, but could instead help the pathogen if it is 
upregulated prior to or during the host’s superoxide attack. Narasipura, Chaturvedi, and 
Chaturvedi showed that pathogen-derived self-upregulation of SOD2 actually contributed to the 
virulence of the fungi, Cryptococcus neoformans gattii, during an infection in mice, providing it 
with the ability to neutralize the host’s superoxide attack19. 
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 To determine the role of SOD2 during a Coxiella infection, we knocked down SOD2 
expression in THP-1 cells using small interfering RNAs (siRNA) and quantified bacterial growth 
within the transfected and non-transfected cells. We hypothesized that if we reduced expression 
of SOD2 and it then decreased bacterial growth, SOD2 most probably benefits the pathogen, 
whereas if it increased the number of intracellular bacteria, the role of SOD2 is as the host’s 
control mechanism for combating the Coxiella infection. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Coxiella culture media preparation 
All work with whole-cell Coxiella burnetii was performed in a biosafety hood by individuals 
with certified training for biosafety level 2 handling. Coxiella media (ACCM-2) was made as 
outlined in Table 1. The pH was adjusted to 4.75, filtered with 0.22µm pore PES membrane 
syringe filter and portioned for storage (10 mL into 15mL falcon tubes). Coxiella cells were 
scraped out of frozen cryo storage tube with an inoculating loop (or specified thawed PBSS stock 
volume) and 1 mL ACCM-2 media in a falcon tube was inoculated. It was then put into 
incubator at 37ᵒC with 5% CO2 and 2.5% O2 on a shaking platform, and grown for at least 3 
days prior to use. 
 
HeLa cell culture media preparation 
All work with whole cell human cells took place in a cell-culture hood.  For 60mm culture petri 
dishes, HeLa cell media was made with 4.5 mL DMEM (Dulbecco minimal Eagle's medium 
without L-glutamine) (Invitrogen) and 0.5 mL fetal bovine serum and supplemental L-glutamine. 
The DMEM and FBS were used alone, without L-glutamine or antibiotics for dilution media 
when splitting cells. A 9:1 ratio of DMEM:FBS with L-glutamine was used for media for 
infections. For regular growth of HeLa cells, a 9:1 ratio of DMEM:FBS with L-Glutamine and 
Pen/Strep (Penicillin/Streptomycin) was used. Transfections took place using media with only 
1% FBS serum with L-glutamine, but without antibiotics.  
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THP-1 cell culture media preparation 
THP-1 Media was prepared with Roswell Park Memorial Institute (RPMI) 1640 medium with 2 
mM L-glutamine, 0.05mM beta mercaptoethanol, and 10% fetal bovine serum (FBS). Pen/Strep 
was added at 1%22. Media was filtered with a (0.2 µm) filter prior to use to filter out any 
microbes from the media. Antibiotics were not used during transfection or infection, and only 
1% FBS was used during transfections.  
 
HeLa cell freezer stock preparation 
Media was pulled off of cells at ~60% confluency (approximately 1 million cells) and the media 
was discarded. Cells were washed with 2 mL phosphate buffered saline (PBS). The PBS was 
removed and cells are trypsinized with 2 mL trypsin and placed into incubator for 5 minutes. 
Trypsinization was verified in microscope, showing that no cells remained adhered to surface of 
plate. 1 mL of FBS ratio was added to the dish to stop trypsinization. Media was moved to a 
falcon tube. Cells were spun down to a pellet in centrifuge for 3 minutes at 500 rpm. Supernatant 
was removed and cells were resuspended in 1 mL of freezing media (1 mL DMSO: 2 mL FBS 
with L-glutamine and pen/strep: 7mL DMEM). Freezing media with suspended cells was 
transferred to a cryotube and placed in styrofoam in a -80 freezer overnight and transferred to 
liquid nitrogen cryo freezer the next day. 
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THP-1 cell freezer stock preparation 
Undifferentiated cells are grown to ~60% confluency (approximately 1 million cells). Media 
used for freezer stocks have 5% DMSO along with growth regular media. 1 mL solution was 
added to cryo tubes, which were put into styrofoam in a -80 freezer overnight, and transferred 
to liquid nitrogen cryo freezer after 24 hours. 
 
Thawing HeLa cells from freezer 
The incubator was turned on and set to 37ᵒC with 5% CO2. Frozen stock was thawed at room 
temperature while DMEM and FBS with L-glutamine and Pen/Strep were warmed in incubator. 
DMEM and FBS were prepared in a 9:1 ratio. 1 mL cryo-frozen HeLa cells were obtained from 
the Singer Lab (Portland State University). Thawed cell stock was put into a falcon tube with 
only DMEM and was centrifuged at 500 RPM for 3 minutes to pellet cells. Liquid was decanted 
into waste and 9mL DMEM and 1 mL FBS, L-glutamine, and Pen/Strep solution are added to 
resuspend the cells. Solution was added to two 60 mm culture dish (5 mL per dish), which were 
then put into incubator set at 37 °C and 5% CO2.  
 
Thawing THP-1 cells from freezer 
The optimum cell density was 1x105 cells/mL to 1x106 cells/mL (max 2x106 cells/mL). No more 
than 5 subsequent passages from freezer stock were performed21. Contents were thawed quickly 
and cell suspension was put into a 15 mL falcon tube with 5mL media. The tube was centrifuged 
at 500 rpm for 3 minutes. Supernatant was discarded, and pellet was resuspended in 10 mL 
media and transferred to two culture dishes (60mm culture dish=5mL). Culture was kept in 
incubator set at 37°C and 5% CO2.  
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HeLa and THP-1 cell culture passaging 
1mL cells were diluted in 4 mL total growth medium (5 mL total) and added to a 60 mm culture 
dish plating density of 15-75% confluency. Percentage confluency was determined by desired 
growth period for experiment. 100 µL of cells are plated for each 10% desired confluency for a 
60mm culture plate and 20 µL for each 10% desired confluency for each well of a 6-well plate. 
The Cell density was verified in an inverted microscope, or counted with a hemocytometer on a 
regular optical microscope. Culture plate with cells were placed into incubator set at 37 ᵒC,  5% 
CO2, with a tray of fresh deionized water in the bottom of the incubator. Media and deionized 
water were changed every 2-3 days. Hela cells cannot be used for more than fifty subsequent 
passages from frozen stock, and THP-1 cannot be used for more than five passages, or one 
month's time.  
 
Differentiation of THP-1 cells 
Cells were split to desired confluency at least 24 hours prior to transfection, unless transfection 
took place during differentiation, or if transfection took place with suspended, undifferentiated 
cells. 1 µg/mL phorbol ester (phorbol 12-myristate 13-acetate) PMA, was added to full serum  
media to initiate differentiation of THP-1 cells into macrophages. Differentiation took place in 
plates that were used for experiment, and not in regular culture dishes. Stock PMA was kept at 
5000x (5mg/mL in DMSO). 2 µl of PMA solution was used for every 10 mL cell media.  
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Transfection- siRNA delivery in adherent cells (HeLa or differentiated THP-1) 
siRNA Buffer 5x was diluted to 1x by mixing with 4x sterile RNase-free water. Solution was 
pipetted up and down 3-5 times while avoiding introduction of bubbles. The solution was placed 
on an orbital mixer/shaker for 70-90 minutes at 37 °C and briefly centrifuged to collect solution 
to bottom of the tube/wells. siRNA aliquots were made for each desired siRNA to a 200nM 
solution in 300ul of 1x buffer. Aliquots were stored in a -20 °C freezer.  
 
In a 2 mL tube, the transfection media was prepared with 900 ul cell culture media 
(without serum). The transfection reagent was added to this volume. Lipofectamine and 
Dharmafect reagents were tried at a variety of volumes, as an attempt to find optimal amount of 
transfection while maintaining a low level of cytotoxicity, but 1ul/well of Dharmafect was the 
final amount used that did not have the cytotoxicity as other products and amounts. Transfection 
media was incubated at room temperature for 5 minutes, before being distributed, 300ul to each 
siRNA (targeting, non-targeting, and buffer only without siRNA) aliquot, which were then 
incubated at room temperature for 20 minutes. 
 
Media was aspirated from adherent cells in 60mm dish and disposed. 1mL of trypsin was 
added to the dish and incubated at 37 °C for 10 minutes. 0.5 mL fetal bovine serum (FBS) was 
added to neutralize the trypsin. The dish was scraped with a cell scraper (for THP-1 cells, HeLa 
cells were easily removed with trypsin alone), and newly suspended cells were counted, and 
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calculated to determine how much was needed to be added to achieve desired amount of cells in 
6-well plate. Up to 360ul  cells in media was added, and that amount was divided by three (since 
it is 1/3 FBS), and the remaining amount of FBS, up to 120ul, was added to 10.2mL serum-free 
media, for a total 1% FBS when siRNA solution was added. 1.7mL cells in media was added to 
prelabeled tubes, corresponding to well identifier. 300 uL from siRNA tubes were added to 
corresponding tubes, with duplicate samples for each siRNA. The 2mL total volume from each 
tube was added to its matching well. Cells were incubated at 37 ᵒC with 5% CO2 for 48 hours 
prior to infection. 
 
Transfection in suspended cells 
In a 2 mL tube, the transfection media was prepared with 900 ul cell culture media (without 
serum). The transfection reagent was added to this volume. Lipofectamine and Dharmafect 
reagents were tried at a variety of volumes, as an attempt to find optimal amount of transfection 
while maintaining a low level of cytotoxicity, but 1ul/well of Dharmafect was the final amount 
used that did not have the cytotoxicity as other products and amounts. Transfection media was 
incubated at room temperature for 5 minutes, before being distributed, 300ul to each siRNA 
(targeting, non-targeting, and buffer only without siRNA) aliquot, which were then incubated at 
room temperature for 20 minutes 
 
The cells that were suspended in media in  the 60mm petri culture dish were aspirated, put into a 
centrifuge tube, and spun down in centrifuge at 500 rpm for 3 minutes to pellet cells. 5 mL 1% 
media was added and pellet was resuspended. Cells were counted and calculated to desired 
amount of cells in 10.2 mL 1% FBS media.  1.7mL cells in media was added to prelabeled tubes. 
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300 uL from siRNA tubes were added to corresponding tubes, for duplicate samples. The 2mL 
total volume from each tube was added to each well. Cells are incubated at 37 °C with 5% CO2 
for 48 hours prior to the Coxiella burnetii infection. Alternatively, adherent cells were plated at 
specified concentration of cells (THP-1 were differentiated) one day prior to transfection in 10% 
FBS, media was aspirated off, and transfection was completed in 1% FBS media as outlined 
above.  
 
Infection of transfected adherent cells with Coxiella burnetii 
After 2-day knock-down, cells were infected with Coxiella burnetii and allowed to grow for 3 
days. 100 ul of Coxiella culture in ACCM2 media, with at least 3 days growth, was added to 
900uL cell growth media in a centrifuge tube. 10ul/well from this mixture was added to 13 mL 
cell media with 10% FBS. Media was aspirated off of wells, and infected media was added to 
wells. Plate was placed in plate bucket in centrifuge and balanced. Coxiella cells were spun 
down onto HeLa or THP-1 cell monolayer for 3 min at 500 rpm. The remaining 1 mL media, and 
the initial inoculate tube were saved for later quantification. These tubes were stored at -80 °C 
until quantification. Cells in plates were placed back in incubator at 37 °C with 5% CO2 for 3 
days. 
 
Infection of transfected suspended cells with Coxiella burnetii 
100ul of Coxiella in ACCM2 and 900 uL cell media were added to a 2 mL centrifuge tube. 10 
uL/mL of this solution was added to 7 mL of cell media, vortexed to mix, and distributed to the 6 
wells. Plates were incubated at 37 °C for 3 days. Inoculate and dilution media were stored at -
80°C until quantified.  
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Quantification of bacterial growth   
For adherent cells, media was removed from wells and discarded. 250uL trypsin was added to 
each well and incubated for 10 minutes. Wells were scraped with cell scrapers to remove any 
remaining adhered cells. Cells in media was removed and spun down, then resuspended in 1 mL 
PBS. For suspended cells, cells in media were pelleted and resuspended in 1 mL PBS. 1 mL 0.2 
mm zirconia beads were added to bead-beating tubes. 1 mL cells in PBS were added to tube.  
 
Tubes were put in bead beater for 2 minutes, cooled on ice for two minutes, and beat again for 
two minutes. 400 uL supernatant was removed and put into new centrifuge tube. 400 uL binding 
buffer was added to tube and mixed well. Complete 800 uL solution was added to column from 
Qiagen GeneJet DNA extraction kit23. Column was centrifuged at 14000 rpm for 1 minute and 
flow-through discarded. 700 uL wash buffer was added to column and centrifuged at 14000 rpm 
for 1 minute and flow-through discarded. Empty column was centrifuged for 1 minute at 14000, 
and placed in new tube. 30uL elution buffer, prewarmed to 56 °C was added to column, 
incubated at room temperature for 10 minutes, then centrifuged at full speed for 1 minute. Flow 
through elution buffer was added back to column and spun again at full speed for one minute. 
2uL of DNA was run through qPCR, using SYBR green protocol23.  
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SOD2 expression analysis 
Cells that had been resuspended in PBS were pelleted down and resuspended in 250 uL TRI, 
then processed as outlined in the TRI reagent protocol26. After RNA extraction, cDNA was made 
using Thermo Fisher cDNA protocol27.  Quantitative Real Time Polymerase Chain Raction 
(qPCR) was conducted with SOD2 and GAPDH primers to quantify amount of SOD2 transcripts 
in relation to number of cells, represented by the GAPDH housekeeping gene.   
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CHAPTER III 
RESULTS 
 
Table 2 shows the Ct values of fluorescence relating to amount of DNA increase per PCR cycle. 
The number indicates how many cycles were necessary to reach the indicated threshold. The A 
wells were run with primers specific to Coxiella, which show the amount of Coxiella DNA in 
each sample. The B wells were run with GAPDH - a human housekeeping gene - primers, which 
show how many copies of this human DNA were present in the sample. A2, A4, B3, and B5 
were transfected with SOD2 siRNA. Samples A3, A5, B4, and B6 were transfected with a non-
targeting siRNA as a control. The A6 and A7 wells were from the initial inoculate on the day of 
infection. The inoculate wells likely did not have enough DNA in the sample to produce a Ct 
value. Table 2 and Figure 3 show a small variance between the bacterial growth rates in the 
SOD2 siRNA and the non-targeting siRNA transfections, but the difference is not significant. 
Figure 4 shows a normal melt curve of both Coxiella and GAPDH primers.  
 
Table 3 and Figure 4 show that the success of the transfection was approximately at 30%, and 
that the difference between the expression rates of SOD2 in the SOD2 siRNA vs. the non-
targeting siRNA were 0.7 and 1, respectively.  
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CHAPTER IV 
DISCUSSION 
 
Table 2 shows that the inoculate wells likely did not have enough DNA in the sample to produce 
a Ct value. This is likely due to the insufficient amount of time to replicate in the inoculate that 
the other samples had. The variance between the samples with the SOD2 transfection, versus the 
non-targeting transfection, are consistent, but not significant. This is consistent with the 
expression analysis of the SOD2 knock-down. Since the transfection only had 30% success, it 
had little impact on the rate of bacterial growth.  
 
Further testing will include optimization of transfection amounts and reagents, including 
liposomes and possible nanoparticle delivery systems. This would help to reduce cytotoxicity, 
while increasing rates of transfection. HeLa cell optimization of delivery was not reached, due to 
cytotoxicity of Lipofectamine and Dharmafect. THP-1 cells had a successful knock-down, but 
the amount of change in expression was not significant enough to reach a conclusion as to 
whether the previously noted 8x increase in SOD2 expression was a benefit to the host or the 
pathogen, or the importance of this expression change during the infection. When a more 
successful transfection method is optimized, the question can be revisited.  
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TABLES AND FIGURES 
 
TABLES 
 
Table 1: Coxiella ACCM-2 Media (100 mL) 
Componants Amount 
Citric acid  256.8 mg 
Sodium citrate (2H2O) 474 mg 
Potassium phosphate  50 mg 
Magnesium Chloride (6H2O) 20 mg 
Calcium chloride (2H2O) 1.32 mg 
Iron Sulfate   (1uM) 
Sodium Chloride 728 mg 
L-cysteine (1H2O) 26.34 mg 
Bacto Neopeptone  10 mg 
Casamino acids 250 mg 
Methyl-b-Cyclodextrin 100 mg 
RPMI w/ glutamax  12.5 mL 
Deionized H2O 86.5 mL 
 
Table 2: qPCR results for infected cells, transfected vs. non
 
 
Table 3: Mitochondrial superoxide 
Raw ct values of all samples 
siRNA type Sample 1 Sample 2
sod2 32.81 31.79
nt 32.03 31.73
siRNA expression differential 
 ct dct 
sod2 32.3 -0.5
nt 31.8  
Adjusted rate of expression to non
 SOD2 expression 
sod2 0.7 
nt 1 
 
 
 
dismutase (SOD2) expression analysis 
 Average 
 32.3 
 31.88 
fold diff 
 0.7071067812 
1 
-targeting siRNA rate 
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FIGURES 
 
Figure 1: Intracellular lifecycle and modulation of host expression through protein effectors 
(Voth and Heinzen, 2007)4 
  
 
 
 
Mn3+-SOD + O
M2+-SOD + O
Figure 2- SOD2-
2
−
 → M2+-SOD + O2 
2
−
 + 2H+ → M3+-SOD + H2O2. 
catalyzed dismutation of superoxide 
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 Figure 3: qPCR amplification of 
transfections with Coxiella and GAPDH primers
Figure 4: Dissociation curves in qPCR for SOD2 and non
Coxiella and GAPDH primers 
Coxiella growth in SOD2 and non-targeting siRNAs 
 
 
-targeting siRNAs transfections with 
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Figure 5: Graphical representation of SOD2 expression in SOD2 siRNA vs non
transfections 
-
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targeting siRNA 
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